Column

Trending From ACCC

Susan Dentzer to Address Disruptive Innovations and the Future of Cancer Care at ACCC 46th Annual Meeting & Cancer Center Business Summit

12/17/2019

JCP Editors

This spring, the Association of Community Cancer Centers (ACCC) is excited to feature Susan Dentzer, senior policy fellow at the Duke-Margolis Center for Health Policy, at the ACCC 46th Annual Meeting & Cancer...

This...

12/17/2019

Journal of Clinical Pathways

Editor's Page

Measuring Quality, Improving Care Delivery

12/17/2019

Winston Wong , PharmD;

In value-based payment models, cost-containment incentives must be counterbalanced by quality measures to ensure that patients are not denied access to appropriate yet potentially costly care. Quality measures are...

In...

12/17/2019

Journal of Clinical Pathways

Clinical Pathways GPS

Speaker Pelosi’s Plan to Lower Drug Costs

11/18/2019

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Matthew Pakizegee , PharmD, MS;

As total cost of care increasingly becomes a major issue in the United States, both market solutions like clinical pathways and government solutions such as drug pricing regulations are being proposed. Each solution...

As...

11/18/2019

Journal of Clinical Pathways

Pharma Insights

How Development of Gene Therapies Impact Decisions on Their Place in Therapy

11/18/2019

Larry Blandford , PharmD;

Aaron Burke ;

Gene therapy has sparked significant interest among researchers, health care providers, and patients because it offers the tantalizing possibility of a cure, particularly for rare diseases with a genetic basis. While...

Gene...

11/18/2019

Journal of Clinical Pathways

Trending From ACCC

ACCC Spotlights Strategies to Improve Care for Senior Adults With Cancer

11/18/2019

JCP Editors

By 2030, it is estimated that 70% of cancers in the United States will be diagnosed in older adults, and by 2040 nearly three-fourths (73%) of the country’s cancer survivors will be aged 65 years or older.1,2 This...

By...

11/18/2019

Journal of Clinical Pathways

Editor's Page

More Comprehensive Pathways to Support Success in Value-Based Reimbursement Models

11/18/2019

Winston Wong , PharmD;

Clinical pathways—defined as structured, multidisciplinary care plans that incorporate evidence-based guidelines and protocols to standardize care—represent a natural strategy for achieving success in the Oncology...

...

11/18/2019

Journal of Clinical Pathways

Editor's Page

Biomarker Testing and Prospective Tracking Tools

10/18/2019

Winston Wong , PharmD;

Even though researchers are making progress every day, the precision medicine approach to cancer treatment is not yet part of routine care. Another strategy that can contribute to more personalized medicine is the...

Even...

10/18/2019

Journal of Clinical Pathways

Editorial

Potential or Unnecessary Burdens and Challenges for Practices Under Proposed CMS Radiation Oncology Model

10/18/2019

Nicolas Ferreyros ;

In July 2019, the Centers for Medicare & Medicaid Services (CMS) proposed a mandatory Radiation Oncology (RO) Model that would require participation to test whether prospective site neutral, episode-based...

In...

10/18/2019

Journal of Clinical Pathways

Business of Pathways

Broadening the Value Assessment Paradigm: Including the Value of Hope and the Value of Insurance

10/18/2019

Sean McElligott , MS;

Ira Klein , MD, MBA, FACP;

*/ /*-->*/ While social media is all about sharing, very little personal preference data makes its way into health plan contracting around specific interventions and pathway programs today. As a result, the...

...

10/18/2019

Journal of Clinical Pathways

Editor's Page

Learning From Pathways Experiences in the Field and Looking in Future Directions

09/20/2019

Winston Wong , PharmD;

*/ /*-->*/ The guidance that comes from clinical pathways encourages widespread and consistent evidence-based practice of medicine by incorporating the most up-to-date clinical guidelines with efficacy and,...

...

09/20/2019

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products